ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : FeRx

Include trials that are no longer recruiting patients.

3 studies were found.
1.CompletedMagnetic-Targeted Doxorubicin in Treating Patients with Cancer Metastatic to the Liver
Conditions: Metastases, Neoplasm; Colorectal Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Melanoma; Sarcoma; ...
2.No longer recruitingSafety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
Condition: Hepatocellular Carcinoma
3.TerminatedSafety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads vs. IV Doxorubicin in Treating Liver Cancer
Condition: Carcinoma, Hepatocellular

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act